AngioScore recall gets class I notification
This article was originally published in Clinica
AngioScore’s recall of its AngioSculpt balloon catheter has been given a class I notification by the US FDA. The firm recalled the AngioSculpt EX percutaneous transluminal coronary angioplasty (PTCA) scoring balloon catheter in December 2009 because it may become separated during use. This could allow fragments of the catheter to become lodged in coronary arteries, leading to serious injury or death. The affected lot of AngioSculpt EX balloon catheters was distributed by the Fremont, California-based company from 30 January until 4 December 2009. AngioSculpt catheters are used to dilate narrowed coronary arteries and improve blood flow to the heart muscle.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals